3 semaglutide Sem-O™ - Getz Pharma Semaglyn Injection (3 ml Cartridge

n = 72 total) in utero found no significant difference in the median rate of infection requiring treatment and/or hospitalization in the year after birth when comparing the exposed and control infants (23.6% [17/72], vs 17.4% [12/69], p = 0.36) [85]

Omegas 3, 6 & 9: Moisture Barrier Protection

1/4 with protein

Elevated circulating levels of OPN, a pro-inflammatory cytokine with a role in immune cell recruitment (240), have been associated with increased CV disease risk in patients with T2D (241)

Reconstitution and handling protocols Peptide calculators help determine appropriate reconstitution volumes, minimizing waste from unused material